Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 12,700 shares, a drop of 18.1% from the January 15th total of 15,500 shares. Based on an average daily volume of 6,300 shares, the short-interest ratio is presently 2.0 days. Approximately 1.4% of the shares of the stock are short sold.
Mannatech Stock Performance
NASDAQ MTEX opened at $11.80 on Friday. The company has a 50 day moving average of $12.31 and a 200-day moving average of $9.37. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44. Mannatech has a 1-year low of $6.75 and a 1-year high of $16.49.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. The firm had revenue of $31.73 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
Analysts Set New Price Targets
Read Our Latest Stock Analysis on MTEX
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- What Investors Need to Know About Upcoming IPOs
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Breakout Stocks: What They Are and How to Identify Them
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- P/E Ratio Calculation: How to Assess Stocks
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.